ILARIS
ILARIS (canakinumab) works to suppress the production of an inflammatory protein. Increased levels of the inflammatory protein IL-1β cause inflammation resulting in symptoms such as fever, joint pain, and rashes. ILARIS stops this inflammatory response.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Cryopyrin-associated Periodic Syndromes (CAPS),
including Familial Cold Autoinflammatory Syndrome (FCAS);
Muckle-Wells Syndrome (MWS);
Neonatal Onset Multisystem Inflammatory Disease (NOMID);
Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS);
Hyper-Immunoglobulin D Syndrome (HIDS);
Mevalonate Kinase Deficiency (MKD);
Familial Mediterranean Fever (FMF);
Adult Onset Still’s Disease (AOSD);
Systemic Juvenile Idiopathic Arthritis (SJIA)
Prescribed by
Various medical specialists
How it’s administered
Subcutaneous injection
Frequency
Monthly or bi-monthly
Length of treatment
10 to 15 minutes